PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.41%
Revenue growth above 1.5x 3141.T's 3.73%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
9.37%
Gross profit growth 1.25-1.5x 3141.T's 6.64%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
0.78%
EBIT growth below 50% of 3141.T's 19.20%. Michael Burry would suspect deeper competitive or cost structure issues.
22.36%
Operating income growth under 50% of 3141.T's 50.69%. Michael Burry would be concerned about deeper cost or sales issues.
5.48%
Net income growth under 50% of 3141.T's 40.32%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.48%
EPS growth under 50% of 3141.T's 40.37%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.48%
Diluted EPS growth under 50% of 3141.T's 40.37%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.00%
10Y revenue/share CAGR under 50% of 3141.T's 78.24%. Michael Burry would suspect a lasting competitive disadvantage.
-5.88%
Negative 5Y CAGR while 3141.T stands at 65.09%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.18%
Negative 3Y CAGR while 3141.T stands at 34.35%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
38.40%
Below 50% of 3141.T's 188.88%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-5.96%
Negative 5Y net income/share CAGR while 3141.T is 61.29%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-29.07%
Negative 3Y CAGR while 3141.T is 31.09%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.52%
10Y equity/share CAGR at 50-75% of 3141.T's 148.12%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
28.29%
Below 50% of 3141.T's 118.05%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-15.26%
Negative 3Y equity/share growth while 3141.T is at 66.36%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-41.67%
Cut dividends over 10 years while 3141.T stands at 8400.25%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-50.00%
Negative 5Y dividend/share CAGR while 3141.T stands at 176.57%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
16.67%
Below 50% of 3141.T's 76.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
16779.31%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
3.78%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
7.63%
Positive asset growth while 3141.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.31%
1.25-1.5x 3141.T's 2.88%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
12.23%
Debt shrinking faster vs. 3141.T's 51.96%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-45.53%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.